Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.20.2
Segment Information (Tables)
9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Schedule of segment reporting information
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
    2020     2019     2020     2019  
Revenues                        
Real property operations   $ 324,982     $ 264,141     $ 923,205     $ 795,656  
Medical related consulting services - related party     -       108,520       -       234,214  
Development services and sales of developed products     -       10,555       -       37,237  
Total     324,982       383,216       923,205       1,067,107  
Costs and expenses                                
Real property operations     135,821       193,738       663,086       617,173  
Medical related consulting services - related party     -       94,442       -       202,908  
Development services and sales of developed products     -       41,808       -       103,899  
Total     135,821       329,988       663,086       923,980  
Gross profit (loss)                                
Real property operations     189,161       70,403       260,119       178,483  
Medical related consulting services - related party     -       14,078       -       31,306  
Development services and sales of developed products     -       (31,253 )     -       (66,662 )
Total     189,161       53,228       260,119       143,127  
Other operating expenses                                
Real property operations     77,852       75,750       291,886       253,347  
Medical related consulting services - related party     160,557       206,085       491,683       446,156  
Development services and sales of developed products     28,002       1,132,015       94,241       1,574,973  
Corporate/Other     3,113,308       4,115,725       8,797,886       12,154,063  
Total     3,379,719       5,529,575       9,675,696       14,428,539  
Other income (expense)                                
Interest expense                                
Real property operations     -       -       -       (32,877 )
Corporate/Other     (41,531 )     (11,198 )     (126,169 )     (27,423 )
Total     (41,531 )     (11,198 )     (126,169 )     (60,300 )
Other income (expense)                                
Real property operations     4       2,157       (927 )     2,172  
Medical related consulting services - related party     (20,095 )     (8,825 )     (36,673 )     (30,679 )
Development services and sales of developed products     221       18       224       197  
Corporate/Other     -       1,160,137       -       1,096,212  
Total     (19,870 )     1,153,487       (37,376 )     1,067,902  
Total other income (expense)     (61,401 )     1,142,289       (163,545 )     1,007,602  
Net income (loss)                                
Real property operations     111,313       (3,190 )     (32,694 )     (105,569 )
Medical related consulting services - related party     (180,652 )     (200,832 )     (528,356 )     (445,529 )
Development services and sales of developed products     (27,781 )     (1,163,250 )     (94,017 )     (1,641,438 )
Corporate/Other     (3,154,839 )     (2,966,786 )     (8,924,055 )     (11,085,274 )
Total   $ (3,251,959 )   $ (4,334,058 )   $ (9,579,122 )   $ (13,277,810 )
Schedule of real property operating
Identifiable long-lived tangible assets at September 30, 2020 and December 31, 2019   September 30,
2020
    December 31,
2019
 
Real property operating   $ 7,662,047     $ 7,750,743  
Medical related consulting services     228,606       263,621  
Development services and sales of developed products     259,301       322,741  
Total   $ 8,149,954     $ 8,337,105  
Schedule of identifiable long-lived tangible assets
Identifiable long-lived tangible assets at September 30, 2020 and December 31, 2019   September 30,
2020
    December 31,
2019
 
United States   $ 7,734,740     $ 7,839,093  
China     415,214       498,012  
Total   $ 8,149,954     $ 8,337,105